CDKN2B and COVID-19: Our study revealed that the frequency of the G/C genotype regarding CDKN2B-AS1 (rs1333049) was significantly higher in severe and moderate COVID-19 patients than in the control group, and the frequency of the C/C genotype was significantly higher in moderate COVID-19 patients than in the control group.